Global Myelofibrosis Therapeutics Market 2018-2022
- Published: Dec 2018
- Pages: 103
- SKU: IRTNTR23859
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global myelofibrosis therapeutics market size will grow by USD 639.26 million during 2018-2022. This industry research report provides a detailed analysis of the market based on the type of treatment (drug therapy, blood transfusion, HSCT, and androgen therapy), and geography (the Americas, APAC, and EMEA). The report analyzes the market’s competitive landscape and offers information on several myelofibrosis therapeutics manufacturers including Bristol-Myers Squibb, CELGENE, Incyte, and Novartis.
Below are some of the key findings from this myelofibrosis therapeutics market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Global myelofibrosis therapeutics industry outlook
The need for disease-modifying drugs for myelofibrosis is driving its therapeutics market. The only FDA approved drug therapy for myelofibrosis is JAKAVI/JAKAFI, but it has dose-related side effects that tend to halt the disease progression to acute leukemia. Other drugs and steroids prescribed by a physician are the off-label ones, which merely focus on prolonging the survival along with the disease. Hematopoietic stem cell transplantation (HSCT) therapy is also having disadvantages regarding the unavailability of matching donors and other therapies only reduce the anemic side-effects of myelofibrosis. Thus, among all treatments available at present, none can be considered as an ideal one that can help in eradicating the disease completely, which makes the need for disease-modifying drugs for myelofibrosis important, driving the myelofibrosis therapeutics market growth at a CAGR of more than 7% during the forecast period.
Top myelofibrosis therapeutics companies covered in this market research report
The global myelofibrosis therapeutics market is extremely concentrated. The market is in the initial stage of the growth phase, and the competition is expected to become less intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this myelofibrosis therapeutics market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.
The report offers a detailed analysis of several leading companies, including:
- Bristol-Myers Squibb
- CELGENE
- Incyte
- Novartis
Myelofibrosis therapeutics market segmentation based on the type of treatment
- Drug therapy
- Blood transfusion
- HSCT
- Androgen therapy
Drug therapy held the largest share of the global myelofibrosis therapeutics market in 2017. The market share of this segment will increase, and it will continue to dominate the market throughout the next five years.
Myelofibrosis therapeutics market segmentation based on region
- The Americas
- APAC
- EMEA
The Americas accounted for the largest myelofibrosis therapeutics market share in 2017. This region will witness an increase in its market share and remain the market leader for the next five years.
Key highlights of the global myelofibrosis therapeutics market for the forecast years 2018-2022:
- CAGR of the market during the forecast period 2018-2022
- Detailed information on factors that will accelerate the growth of the myelofibrosis therapeutics market during the next five years
- Precise estimation of the global myelofibrosis therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the myelofibrosis therapeutics industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of myelofibrosis therapeutics companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: PIPELINE ANALYSIS
- Pipeline analysis
PART 06: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: MARKET SEGMENTATION BY TYPE OF TREATMENT
- Segmentation by type of treatment
- Comparison by type of treatment
- Drug therapy – Market size and forecast 2017-2022
- Blood transfusion – Market size and forecast 2017-2022
- HSCT – Market size and forecast 2017-2022
- Androgen Therapy – Market size and forecast 2017-2022
- Market opportunity by type of treatment
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas – Market size and forecast 2017-2022
- EMEA – Market size and forecast 2017-2022
- APAC – Market size and forecast 2017-2022
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- HSCT is the only curative option for myelofibrosis
- High off-label prescription including hydroxyurea, Immunomodulators, and steroids
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bristol-Myers Squibb
- CELGENE
- Incyte
- Novartis
PART 16: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
